Enteris BioPharma has appointed Joel Tune as chief executive officer. In addition, Paul Shields is promoted to chief operating officer. Mr. Tune and Dr. Shields, along with Brian Zietsman, president and chief financial officer, will be responsible for leading Enteris BioPharma as the company pursues strategic alternatives to capitalize on multiple growth opportunities involving its proprietary oral delivery technology, highly-differentiated product pipeline, and cGMP compliant recombinant peptid...